Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Diabetic Macular Edema · Hypercholesterolemia · REGN

Regeneron UK

Regeneron UK Limited

Regeneron UK clinical programs — 493 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Tarrytown, USA HQ
16,715 Employees
Public company Type
REGN · NYSE Ticker
Company details
Status
Public
HQ
Tarrytown, USA
Employees
16,715
Programs
493
Drugs
98
Patents
837
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Regeneron UK projects

493 ClinicalTrials.gov programs sponsored by Regeneron UK.

Regeneron UK has 493 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

493 programs

Clinical programs

Page 8 of 11

  1. Cisplatin

    Regeneron UK Limited

    Head and Neck Cancer

    phase 1 small molecule active

    1 trial

  2. Dupilumab

    Regeneron UK Limited

    Atopic Disorders

    phase 1 small molecule completed

    1 trial

  3. Dupilumab (SAR231893)

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  4. Dupilumab (SAR231893)

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  5. Evinacumab

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. Fasinumab

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  7. Fasinumab AI

    Regeneron UK Limited

    Osteoarthritis, Knee

    phase 1 small molecule completed

    1 trial

  8. Garetosmab

    Regeneron UK Limited

    Obesity

    phase 1 small molecule terminated

    1 trial

  9. Ipilimumab

    Regeneron UK Limited

    Stage III Prostate Cancer

    phase 1 mab terminated

    1 trial

  10. Itepekimab AI

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease

    phase 1 small molecule completed

    1 trial

  11. Odronextamab

    Regeneron UK Limited

    B-cell Non-Hodgkins Lymphoma (B-NHL)

    phase 1 small molecule active

    1 trial

  12. Odronextamab multiple dose levels

    Regeneron UK Limited

    Non-Hodgkin Lymphoma

    phase 1 small molecule completed

    1 trial

  13. Placebo

    Regeneron UK Limited

    Atopic Dermatitis

    phase 1 small molecule completed

    3 trials

  14. Pozelimab

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  15. Pozelimab

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  16. Pozelimab

    Regeneron UK Limited

    Geographic Atrophy (GA)

    phase 1 small molecule active

    1 trial

  17. Pozelimab/Cemdisiran

    Regeneron UK Limited

    Sporadic Inclusion Body Myositis (sIBM)

    phase 1 other active

    1 trial

  18. REGN1033

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  19. REGN1033

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  20. REGN1033 (SAR391786)

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  21. REGN10933+REGN10987

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  22. REGN1154 or placebo

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. REGN1193

    Regeneron UK Limited

    Diabetes Mellitus, Type 2

    phase 1 small molecule terminated

    1 trial

  24. REGN1193

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  25. REGN13335

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  26. REGN1400

    Regeneron UK Limited

    Cancer

    phase 1 small molecule completed

    1 trial

  27. REGN14284

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  28. REGN1500

    Regeneron UK Limited

    Metabolic Disorders

    phase 1 small molecule completed

    1 trial

  29. REGN1500

    Regeneron UK Limited

    Hypertriglyceridemia

    phase 1 small molecule completed

    1 trial

  30. REGN15160 (IV)

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  31. REGN17092

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  32. REGN1908-1909

    Regeneron UK Limited

    Allergy

    phase 1 small molecule completed

    2 trials

  33. REGN2009

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  34. REGN20423

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule active

    1 trial

  35. REGN20934

    Regeneron UK Limited

    Overweight or Obesity

    phase 1 small molecule active

    1 trial

  36. REGN2176-3

    Regeneron UK Limited

    Neovascular Wet Age-related Macular Degeneration (AMD)

    phase 1 small molecule completed

    1 trial

  37. REGN22044

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule active

    1 trial

  38. REGN2222

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  39. REGN2222(SAR438584)

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  40. REGN2477

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  41. REGN2810

    Regeneron UK Limited

    Recurrent Squamous Cell Carcinoma of Head

    phase 1 small molecule completed

    1 trial

  42. REGN2810

    Regeneron UK Limited

    Advanced Malignancies

    phase 1 small molecule terminated

    1 trial

  43. REGN2810

    Regeneron UK Limited

    Melanoma

    phase 1 small molecule completed

    1 trial

  44. REGN3470-3471-3479

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  45. REGN3500

    Regeneron UK Limited

    Asthma, Allergic

    phase 1 small molecule completed

    1 trial

  46. REGN3500

    Regeneron UK Limited

    Asthma

    phase 1 small molecule completed

    1 trial

  47. REGN3500

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  48. REGN3767

    Regeneron UK Limited

    Malignancies

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Regeneron UK have?

493 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.